I don’t remember the criteria, but my hope is that CYDY can hold these gains in the coming weeks and uplist accordingly. The filing of the BLA, with further positive cancer and COVID19 data should assist with keeping it above $2.

IMO, uplisting will also bring a bump in the SP.